ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2021 American Transplant Congress

    A Comparative Analysis of Kidney Allograft Outcomes in Steroid Use versus Steroid Discontinuation After Basiliximab Induction: Unos Data Base Study

    F. Cardarelli, H. Patel, A. Aala

    Nephrology, BIDMC, Boston, MA

    *Purpose: Basiliximab is a monoclonal antibody produced by recombinant DNA technology used by many transplant centers in the U.S. as induction immunosuppression. When Basiliximab is…
  • 2021 American Transplant Congress

    The Clinical Significance of Preformed C1q-binding Donor-specific HLA Antibodies in Kidney Transplantation

    S. Lee1, C. Yang2, B. Chung2

    1Seoul National University Hospital, Seoul, Korea, Republic of, 2Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of

    *Purpose: Complement activation is one dominant mechanism which cause allograft injury in kidney transplantation (KT). Anti-HLA donor-specific antibodies (DSA) that bind to HLA molecules on…
  • 2021 American Transplant Congress

    Early Reduction of Tacrolimus Trough Levels Improves Long-term Kidney Function without Increase in Incidence of Acr

    M. Chen1, B. Loza1, A. Chang1, R. Byfield2, K. Olthoff1, A. Shaked1

    1Department of Surgery, University of Pennsylvania, Philadelphia, PA, 2Data Analytics Center, Penn Medicine Information Systems, University of Pennsylvania Health System, Philadelphia, PA

    *Purpose: We examined the impact of clinical practice management of tacrolimus trough levels in liver transplant recipients on kidney function and incidence of rejection in…
  • 2021 American Transplant Congress

    The Impact of Tacrolimus IPV and TTR on the Development of De Novo Donor-specific Antibodies in Kidney Transplant Recipients

    D. Xu1, K. Richards1, K. Zheng1, H. Patel2, F. Cardarelli2, J. A. Pena3, A. Aala2

    1Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, 2Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, 3Pathology, Beth Israel Deaconess Medical Center, Boston, MA

    *Purpose: High intrapatient variability (IPV) and low time in therapeutic range (TTR) of tacrolimus (TAC) may increase the risk of developing de novo donor-specific antibodies…
  • 2021 American Transplant Congress

    Leflunomide Therapy for Treatment of Bk Viremia in Pediatric Kidney Transplant Recipients

    A. Aldieri1, M. Chandran2, D. Matossian3, B. Magella4, D. Lazear4, M. Bock2, E. Blanchette2

    1Children's Hospital Colorado, Denver, CO, 2Children's Hospital Colorado, Aurora, CO, 3Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 4Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    *Purpose: BK viremia (BKV) after kidney transplantation (KT) poses significant risk for BK virus-associated nephropathy (BKVN) and impacts graft survival. Conventional treatment involves reduction of…
  • 2021 American Transplant Congress

    Worsening Impact of Acute Kidney Rejection on Long Term Graft Survival from 2000 to 2014

    D. Leeser1, W. Irish1, K. Ravindra2, V. Villani2, A. Connor2, J. Tuttle1

    1Surgery, East Carolina University, Greenville, NC, 2Surgery, Duke University, Durham, NC

    *Purpose: Acute rejection (AR) has been shown to impact graft survival after kidney transplant (KTx), however there is limited data on its impact on long…
  • 2021 American Transplant Congress

    Inflammation in Scarred Cortex (i-IFTA) is Significantly Associated with T Cell-mediated Rejection (TCMR), but Not Antibody-mediated Rejection (ABMR), in Renal Allograft Biopsies (Bx)

    H. Zhang

    Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA

    *Purpose: I-IFTA in renal allograft Bx has been found to be associated with decreased death-censored graft survival. Moderate to severe i-IFTA (2 or 3) is…
  • 2021 American Transplant Congress

    A Comparison of Plasmapheresis Methods in the Treatment of Late Antibody Mediated Rejection

    Y. Caliskan1, H. Yazici2, A. B. Dirim2, E. Aksoy2, S. Safak2, N. Garayeva2, S. Mirioglu2, O. Yegit2, O. A. Oto2, Y. Ozluk3, S. Besisik4, A. Turkmen2, K. Lentine1

    1Saint Louis University, Saint Louis, MO, 2Division of Nephrology, Istanbul University, Istanbul, Turkey, 3Department of Pathology, Istanbul University, Istanbul, Turkey, 4Division of Hematology, Istanbul University, Istanbul, Turkey

    *Purpose: Effective management to prevent allograft loss after late antibody mediated rejection (ABMR) in kidney transplant (KTx) recipients remains a vexing clinical challenge. While plasma…
  • 2021 American Transplant Congress

    Murine Cytomegalovirus Induces Kidney Allograft Injury via Th17 Cells Recruited by Both Viral Antigen-Specific and Cytokine/chemokine Mediated Pathways

    R. Dhital1, V. Velazquez1, Q. Zeng2, B. Graber1, K. Flint1, M. Shimamura1

    1Vaccines and Immunity, Nationwide Children's Hospital, Columbus, OH, 2Center for Cardiovascular Research, Nationwide Children's Hospital, Columbus, OH

    *Purpose: Cytomegalovirus infection in transplant recipients has been associated with renal allograft rejection and graft failure. We have previously shown that murine CMV (MCMV) infected…
  • 2021 American Transplant Congress

    Combined Donor Derived Cell Free DNA (AlloSure) and Peripheral Immune Cell Gene Expression (AlloMap) Testing for the Diagnosis of Rejection in Kidney Transplant Recipients with De Novo Donor Specific Antibodies

    K. R. Degner, S. Parajuli, F. Aziz, N. Garg, D. Mandelbrot, M. Mohamed, K. Van Hyfte, S. R. Reese, N. A. Wilson, A. Djamali

    University of Wisconsin, Madison, WI

    *Purpose: Combined donor-derived cell-free DNA (dd-cfDNA, AlloSure) and peripheral immune cell gene expression (AlloMap) may increase the predictive value of de novo DSA (dnDSA) for…
  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences